Afatinib plus EGF pathway targeting immunization (EGF-PTI) as first line therapy for EGFR mutant NSCLC: The EPICAL study
No Thumbnail Available
Identifiers
Date
2018-04-01
Authors
Karachaliou, N.
Cardona Zorrilla, A.
Rodriguez-Abreu, D.
Cobo Dols, M.
Reguart Aransay, N.
Viteri, S.
Codony-Servat, J.
Molina-Vila, M. A.
D'Hondt, E.
Rosell, R.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
